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Summary
Objective: The objective of this study was to investigate CD44 and proteoglycan metabolism in patients suffering from KashineBeck Disease
(KBD), an endemic osteoarthropathy that affects 2.5 million of 30 million people living in the KBD regions of China.
Methods: Immunohistochemical analyses of cluster of differentiation-44 (CD44), BC-13 and 3-B-3() expression were performed in cartilage
sections harvested from KBD and normal patients. In addition, the serum levels of soluble CD44 (sCD44), interleukin-1beta (IL-1b), tumor
necrosis factor-alpha (TNF-a) and matrix metalloproteinase-1 were determined using a sandwich enzyme linked immunosorbent assay.
Results: Hematoxylin & eosin and toluidine blue staining indicated that there was cell necrosis and proteoglycan loss in cartilage from both
KBD children and adult cartilage. Strong immunohistochemical staining for CD44, BC-13 and 3-B-3() occurred in the majority of adult KBD
patients and most KBD children. Furthermore, statistically signiﬁcant elevated levels of sCD44, IL-1b and TNF-a were found in the sera of both
adult and child KBD patients when compared to the levels of normal adult and child controls. Interestingly, IL-1b and TNF-a serum levels were
all high in normal children from KBD regions when compared to normal children from non-KBD regions suggesting that unidentiﬁed factors
(e.g., a genetic predisposition) may protect some people from KBD pathology.
Conclusion: Our results demonstrate that altered CD44, IL-1b and TNF-a metabolism occurs in the pathogenesis of KBD and there is an
increased aggrecanase-generated proteoglycan loss from KBD adult and child cartilage. These primary metabolic changes are likely to be
signiﬁcant contributing factor causing pathological joint formation and instability that leads to secondary osteoarthritis in KBD patients.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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KashineBeck Disease (KBD) is an endemic, chronic, and
degenerative osteoarthropathy, which is manifests primarily
in agricultural regions of Asia especially in the central re-
gions of the PR China. KBD often occurs in children and
is age-related. The symptoms include joint pain, morning
stiffness in the joints, disturbances of ﬂexion and extension
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680motion in the middle-sized and large joints of the body
(Fig. 1). Pathologically, the epiphyseal plate of cartilage
from young and adolescent patients shows necrosis in the
hypertrophic layer near the adjacent subchondral bone
thus explaining why these young KBD patients often have
severe joints’ deformities during development1. At present
the etiology of KBD is unclear. One of the most popular
hypotheses is that KBD is caused by fungal mycotoxins
on stored food, especially T-2 toxin2. Other etiologies occur
including selenium deﬁciency in soil and water in the KBD
areas; nutrition deﬁciency and virus infections. Nonethe-
less, all of these hypotheses still lack adequate experimen-
tal evidence to support their proposal.
Osteoarthritis (OA) is a degenerative joint disorder that
predominantly occurs in older people worldwide3. It has
been suggested several years ago that a high prevalence
of primary OA occurs in the KBD areas4. Thus, onemight hy-
pothesize that, in individuals moving into an endemic KBD
area during adult life after growth plate closure, their articular
cartilagewould besusceptible to damage from theKBDcaus-
ing agents resulting in the onset of a generalized secondary
Fig. 1. Enlarged hand and knee joints of KBD patient. The patient
was female, 56 years old, and was diagnosed as KBD stage III
by X-ray.
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this hypothesis, there is a possible relationship betweenKBD
and OA in their pathogenic pathways in spite of their different
etiologies.
One of the central pathophysiological features contribut-
ing to cartilage erosion during OA is the catabolism and
loss of the aggregating cartilage proteoglycan aggrecan5.
Aggrecan exists as large aggregates in cartilage matrix via
the interaction of its G1 domain with hyaluronan (HA) and
link protein6e8. It has been conﬁrmed that the accelerated
loss of the aggrecan, and the consequent loss of glycosami-
noglycan-bearing aggrecan fragments from articular carti-
lage, is an early event in the destruction of the articular
cartilage seen in the pathogenesis of OA and rheumatoid
arthritis (RA)9. The loss of aggrecan results in a decrease
in functional and structural integrity of the cartilage matrix,
which consequently makes the tissue lose its capacity to
resist compression under load, eventually leading to irre-
versible mechanical and further enzymatic destruction of
the cartilage10. Many proteolytic enzymes are involved in
the process including a disintegrin-like and metalloprotease
with thrombospondin motifs-4 and -5 (ADAMTS-4 and -5)
and matrix metalloproteinases (MMPs). Several studies
have identiﬁed the aggrecanases as the major proteases
responsible for aggrecan degradation and loss from the car-
tilage at the early stage of degenerative joint disease5,9,10.
The major proteolytic cleavage site responsible for cartilage
pathology occurs in the interglobular domain (IGD) between
Glu373 and 374Ala5,10. Monoclonal and polyclonal antibodiesare available to detect the neoepitopes generated at the
aggrecanases and MMP cleavage sites in aggrecan5,10.
Cluster of differentiation-44 (CD44) is a membrane gly-
coprotein and the primary HA receptor on chondrocytes in
articular cartilage. It contains a hydrophobic transmem-
brane domain followed by a 70-amino acid intracellular
domain11. The intracellular domain of CD44 contains
motifs with the potential for transducing signals and
controlling the spatial organization of the receptor in the
plasma membrane, which is very important for cellematrix
interactions and proteoglycan retention around the chon-
drocyte. There is an accumulating evidence suggesting
that perturbation of CD44 metabolism occurs during OA
pathogenesis, although it is not clear whether this abnor-
mal metabolism is a primary factor or just a consequence
of the overall altered cartilage metabolism12e14.
KBD is a unique endemic arthropathy that appears to have
a different etiology when compared with OA, but it does have
similar pathological outcome involving cartilage matrix degra-
dation, leading to joint destruction.Todate, therehavebeenno
studies investigating themetabolism of aggrecan andCD44 in
KBD patient articular cartilage. In this study, we found that
there was signiﬁcant aggrecanase-mediated proteoglycan
degradation in both adult and child KBD patients and altered
CD44 metabolism was also involved in KBD pathogenesis.Patients and methodsMATERIAL SOURCESChild KBD cartilage samples were obtained from ﬁnger joints from four
KBD patients aged from 3 through 7 years old with documented X-ray diag-
nosis of KBD. These children had died from accidents or other diseases such
as bacillary dysentery. The adult cartilage samples were obtained from 16
KBD patients undergoing joint replacement surgery and were aged from
35 through 63 years old. The cartilage samples from the normal children
and adults were obtained from patients who had died from clinical problems
not involving joint pathology. Ethical approval for acquisition of these patient
samples was approved by The Human and Ethical Committee for Medical
Research at Xi’an Jiaotong University, School of Medicine (Dr Yong Liu,
Director); documents have been provided to the Osteoarthritis Research So-
ciety International (OARSI). Ethics Committee with this paper submission.
Both pathological (KBD) and normal cartilage samples were obtained within
2e4 h of death and ﬁxed in 4% paraformaldehyde. KBD patient serum sam-
ples came from a separate KBD epidemiological survey where participants
were subjected to X-ray diagnosis and blood collection. There were 18
KBD children (4e12 years old) samples, 18 normal children from a KBD
area (4e12 years old) samples and 20 KBD adult samples (28e55 years
old) from KBD areas of Shaanxi Province, PR China. Normal serum samples
were obtained from people undergoing routine health examination in a non-
KBD region. All of the patients and normal samples were obtained after get-
ting the patient or guardian’s consent as authorized by the Ethics Committee
of Ministry of Health, Shaanxi Province.IMMUNOHISTOCHEMICAL STAINING FOR CD44 AND
NEOEPITOPES OF AGGRECAN METABOLISMCartilage was dissected from the subchondral bone, paraformaldehyde-
ﬁxed and then the parafﬁn-embedded cartilage samples were cut into
6-mm sections and placed on poly-L-lysine-coated glass slides. Immunohisto-
chemical staining was performed with primary antibodies, biotin-conjugated
secondary antibodies followed by detection using the strepteavidinebiotine
peroxidase complex (SABC) method (SABC kits: Boster Co, Wuhan, China).
Brieﬂy, after deparafﬁnization, endogenous peroxidase was blocked with 3%
H2O2 for 15 min and the slides were washed with 0.01 M phosphate-buffered
saline (PBS). The slides were then predigested using prewarmed (37C)
0.1% trypsin (Maixin-Bio Co, Fuzhou, China) or 10 U/ml chondroitinase
ABC (Sigma, USA), followed by rinsing with distilled water. After blocked
using 10% normal goat serum, the sections were incubated with monoclonal
antibodies recognizing either CD44 (Boster Co, Wuhan, China), BC-13
(Abcam, Cambridge, UK) or 3-B-3 (Seikagaku, Japan) or PBS as negative
control for 18 h at 4C followed by incubation with 1:200 biotinylated goat
anti-mouse IgG (Boster Co, Wuhan, China). After incubation with the
SABC complex, the sections were stained with 3-amino-9-ethylcarbozole.
Counterstaining was performed with hematoxylin.
682 J. Cao et al.: Articular cartilage metabolism in patients with KBDQUANTIFICATION OF CD44 POSITIVE CELLSThe stained slides were examined microscopically. Quantiﬁcation of
CD44 positive cells was performed over several different areas of each sec-
tion. The percentage of positive cells was evaluated by counting 10 high
magniﬁcation power ﬁelds (40) in three consecutive tissue sections, using
the following semi-quantitative criteria: 0¼ negative; 1þ¼ less than 25%
positive staining; 2þ¼ 25e50% positive staining; and 3þ¼ greater than
50% positive staining.INVESTIGATION OF THE SERUM LEVELS OF SOLUBLE CD44
(sCD44) AND CYTOKINES IN KBD PATIENTSsCD44 analysis was performed using enzyme linked immunosorbent
assay (ELISA) kits (R&D Systems, UK) and the serum levels of interleu-
kin-1beta (IL-1b), tumor necrosis factor-alpha (TNF-a) and MMP-1 in pa-
tients were determined using ELISA kits from Jingmei Biotech Co, Ltd,
PR China. These sandwich ELISAs were carried out according to the sup-
plier’s protocols and optical densities were determined using an automated
reader (Biorad Co, USA). The concentration of sCD44 was determined
using Microman2-reader software (Biorad Co, USA).STATISTICAL ANALYSISData are presented as mean S.E.M. Data were checked for normal distri-
bution and equal variance. Student’s t test for independent samples or one-
way analysis of variance was carried out by SPSS 12.0 software. Differences
were considered signiﬁcant at P values of less than 0.05.ResultsHISTOCHEMICAL ANALYSESHematoxylin and eosin (H&E) staining of cartilage from
normal and KBD patients is shown in Fig. 2. In the normalFig. 2. H&E staining of cartilage from a normal child (A) and normal adult (
12-year-old child with no known history of joint disease. (B and C) 7-yea
pertrophic layer (B and C), with some cellular cluster formation above
KBD adult cartilage. There is a region with chondrocytes absenchild cartilage, extensive matrix and cellular lacunae can
be clearly seen [Fig. 2(A)]. However, in the KBD child artic-
ular cartilage, chondrocyte necrosis is seen in the lower
hypertrophic layer, where few chondrocytes are found.
Interestingly, there are also many cell clusters in areas
above the sites of necrosis [Fig. 2(B) and (C)]. The cartilage
surface of the normal adult was smooth, and chondrocytes
were prevalent with territorial matrix staining around the
chondrocyte in the hypertrophic layer and the tide-mark
can be clearly seen [Fig. 2(D)]. In contrast, the cartilage
from the KBD adult was ﬁbrillated at the surface, and chon-
drocytes were absent in many areas especially in the deep
layer where territorial matrix staining was absent. In addi-
tion, cell clusters were present above this area and no
tide-mark was evident [Fig. 2(E) and (F)].
An example of toluidine blue staining of KBD child and
adult articular cartilage is shown in Fig. 3. Strong toluidine
blue staining was present throughout the depth of the
normal child and adult articular cartilage [Fig. 3(A) and
(D)]. In the cartilage from the KBD child [Fig. 3(B) and
(C)], the staining in superﬁcial and middle zones is similar
to that seen in the normal child cartilage [Fig. 3(A)]. How-
ever, in the deeper hypertrophic layer, there are areas of
weak staining, which coincide with the regions of chondro-
cyte necrosis are shown in Fig. 2(B) and (C). In the KBD
adult cartilage, the staining was weak in all zones of the
cartilage section compared with that from normal adult
cartilage, especially in the superﬁcial zone. In addition, ter-
ritorial matrix staining is decreased in the areas surround-
ing the cell clusters above the necrotic zones [Fig. 3(E)
and (F)].D), as well as a KBD child (B and C) and a KBD adult (E and F). (A)
r-old KBD patient. There is a band of overt cell necrosis in the hy-
it (C). (D) Normal adult without history of joint disease. (E and F)
t above the subchondral bone, and no obvious tide-mark.
Fig. 3. Toluidine blue staining of the cartilage from a normal child (A) and a normal adult (D), as well as a KBD child (B and C) and a KBD adult
(E and F). These sections were generated from the same samples as in Fig. 2. (A) 12-year-old child with no known history of joint disease. (B
and C) 7-year-old KBD patient. The presence of areas with cell necrosis and cell clusters is similar to those seen with H&E staining in Fig. 2. In
addition, reduced toluidine blue staining is evident in the KBD patient cartilage around the cell clusters above the necrotic regions of both child
and adult cartilage.
683Osteoarthritis and Cartilage Vol. 16, No. 6CD44 IMMUNOHISTOCHEMISTRYExamples of CD44 immunohistochemical staining in KBD
patients and normal cartilage from both adults and children
are shown in Figs. 4 and 5, respectively. Strong positive
immunostaining for CD44 was only found in KBD patient
cartilage from both adults and children. This was predomi-
nantly present in the lacunae of the KBD patients with
some weak matrix staining. A summary of the analyses
for CD44 immunostaining in all of the groups of normal
and KBD cartilage (adult and child) was semi-quantiﬁed
and is presented in Table I. Strong (þþþ) CD44 positive
staining was found in 14 of the 16 adult patients, staining
in two samples was moderate and no KBD patients had
weak or negative staining (Table I). In contrast to the adult
KBD samples, negative (two samples) or weak (two sam-
ples) CD44 immunostaining was found in normal adult car-
tilage sample (Table I). In the cartilage samples from the
four KBD children, strong CD44 staining was found in three
of them and weak staining in only one sample. Negative
staining for CD44 was found in all three normal children
cartilage samples that were analyzed (Table I).sCD44 LEVELS IN NORMAL AND KBD PATIENTSWe also determined the sCD44 levels in KBD patients
and normal people. The results of ELISA analyses of serum
from patients are provided in Table II. Statistical analysis of
these samples showed that the serum sCD44 level in KBD
children was signiﬁcantly higher than that of normal children
from a non-KBD area (P< 0.01). Serum sCD44 levels fromKBD adult patients were increased almost two-fold when
compared to that of the normal adults from a non-KBD
area (P< 0.01). In addition, the serum sCD44 levels from
both the normal and KBD children were much higher than
that found in the normal and KBD adults, i.e., 1062.01
and 1389 ng/ml compared with 362.72 and 660.88 ng/ml,
respectively (Table II).IMMUNOSTAINING FOR ANABOLIC AND CATABOLIC
NEOEPITOPES IN KBD PATIENT ARTICULAR CARTILAGEImmunostaining for the aggrecanase-generated .NI-
TEGE373 neoepitope with monoclonal antibody BC-13
was performed on cartilage obtained from KBD and normal
children (Fig. 6). There was no BC-13 positive staining in ar-
ticular cartilage from a 12-year-old normal child [Fig. 6(A)].
In contrast, intense BC-13 staining occurred in cartilage ob-
tained from a 7-year-old KBD child [Fig. 6(B)]. This BC-13
positive staining was seen in superﬁcial, middle and deep
zones, but mainly in the chondrocyte lacunae as well as
a weaker staining in the territorial matrix [Fig. 6(B)]. No sig-
niﬁcant aggrecanase-generated BC-13 positive staining
was seen in normal adult cartilage [Fig. 6(C)], but in con-
trast, there was signiﬁcant positive BC-13 staining in the
matrix of the adult KBD cartilage in particular in the surface
zone [Fig. 6(D)].
Immunolocation with monoclonal antibody (mAb) 3-B-3 on
normal and KBD children articular cartilage was usedwithout
prior chondroitinase predigestion, i.e., 3-B-3(), see Fig. 7.
Under this condition, 3-B-3() identiﬁes a ‘‘native’’ chondroi-
tin sulfate (CS) glycosaminoglycan epitope that occurs at the
Fig. 4. CD44 immunostaining in normal and KBD adult cartilage (positive staining is red). (A and B) Adult KBD cartilage: A e staining of su-
perﬁcial and middle zones and B e staining of deep zone of KBD articular cartilage. (C and D) Normal adult cartilage: C e superﬁcial zone and
D e superﬁcial and middle zones. (E) Negative control with PBS used instead of anti-CD44 primary antibody.
684 J. Cao et al.: Articular cartilage metabolism in patients with KBDnon-reducing terminal of some of theCS chains in newly syn-
thesized aggrecan which is often present in OA carti-
lage15,16. There was no 3-B-3() positive staining in
cartilage of normal children [Fig. 7(B)]. However, there was
intense 3-B-3() staining in the surface and middle zones
of the cartilage from the KBD child [Fig. 7(A)] with slightly
weaker staining in the deep zone.ANALYSIS OF LEVELS OF IL-1b, TNF-a AND MMP-1 IN SERUM
FROM NORMAL AND KBD PATIENTSELISA analyses were used to determine the serum levels
of IL-1b in normal and KBD patients (Table III). The serum
levels of IL-1b in KBD children were signiﬁcantly (P< 0.05)
higher than that of the normal children in a non-KBD region.
Interestingly, statistical analyses indicated that the serumIL-1b levels in both KBD children and normal children
from a KBD region were higher than that found in the nor-
mal children from a non-KBD region (P< 0.05). However,
there was no signiﬁcant difference in the serum IL-1b levels
between the KBD children and the normal children from
a KBD region. Similarly, ELISA quantiﬁcation indicated
that the serum IL-1b levels of KBD adult patients were sig-
niﬁcantly higher than that of normal adults from the non-
KBD region (P< 0.05).
ELISA quantiﬁcation for the serum levels of TNF-a in chil-
dren and adult KBD patients is also shown in Table III.
Here, serum TNF-a levels in normal children from a KBD re-
gion were the highest and those of control children from
a non-KBD region were the lowest. Statistical analyses
showed that serum TNF-a levels of both KBD and normal
children from a KBD region were higher than that of the
Fig. 5. CD44 immunostaining in KBD and normal child cartilage (positive staining is red). (A) KBD child cartilage where CD44 immunostaining
is strong in the chondrocyte lacuna. There is also some weaker staining in the territorial matrix. (B) Normal child cartilage where there is no
positive CD44 staining. (C) Negative control with PBS used instead of anti-CD44 primary antibody.
685Osteoarthritis and Cartilage Vol. 16, No. 6normal children from a non-KBD area (P< 0.05). However,
there was no signiﬁcant difference in serum TNF-a level
between KBD children and normal children from a KBD
region. In addition, the serum TNF-a levels in KBD adult
patients were signiﬁcantly higher than that of normal adults
from a non-KBD region (P< 0.05).
Finally, serum MMP-1 levels in normal children from the
non-KBD region, normal children from KBD region and
KBD child patients’ sera were also determined by ELISA
and the results are shown in Table III. Here, the serum
MMP-1 levels in KBD children were the highest and that
of the normal children from non-KBD area were the lowest.
However, statistical analysis showed that there was no sig-
niﬁcant difference in serum MMP-1 levels of all three groups
(P> 0.05).Discussion
The histochemical, immunohistochemical and biochemi-
cal analyses of tissue and sera obtained from KBD patients
(children and adult) show several similarities and differ-
ences to those found in similar analyses of patients with
degenerative joint disease. Histochemical analyses (H&E
and toluidine blue) of articular cartilage sections obtained
from children and adults KBD patients showed evidence
for cellular necrosis and reduced proteoglycan content
and surface ﬁbrillation similar to that observed in different
stages of the progression of degenerative joint diseases.
In general, the presence of cellular necrosis occurred in
patches above the subchondral bone, whilst diminished
matrix staining occurred throughout all morphological zones
of KBD patients’ cartilage, which contrasts that generally
found in the analyses of osteoarthritic cartilage where a pro-
gressive degeneration from the surface to deeper cartilageTable I
Immunohistochemical expression of CD44 in normal and KBD
cartilage tissues
Level of expression Adult Children
KBD Normal KBD Normal
Negative 0 2 0 3
þ 0 2 1 0
þþ 2 0 0 0
þþþ 14 0 3 0zones is observed16. This decrease in matrix staining was
also present around chondrocyte clusters. At present, the
mechanisms involved in chondrocyte necrosis in KBD pa-
tients are unclear. However, previous studies have shown
that the cell apoptosis pathway may be involved in its
pathogenesis17.
Immunohistochemical analyses for CD44 expression in
KBD patient and healthy articular cartilage indicated that
CD44 was readily detectable around the periphery of chon-
drocytes in sections from both child and adult KBD patients
but this expression was weak or absent in analyses of nor-
mal or child cartilage, respectively. This ﬁnding suggests
that CD44 expression is up-regulated in KBD pathology
and may be indicative of increased cartilage matrix metab-
olism in this disease. This result is similar to that found in
the other degenerative joint diseases such as OA and RA
where there was an increased expression of CD44 in the
cartilage and synovial ﬂuid18,19. These immunohistochemi-
cal ﬁndings are paralleled with the quantiﬁcation of an
increase in the levels of serum sCD44 in KBD patients
when compared to that found in normal patients. sCD44 is
found in serum and lymph. Its functions are not clear, but
many studies have observed increased circulating levels
of sCD44 in many diseases20e22. Our results show that
signiﬁcant increase in CD44 expression occurred in KBD
patient cartilage, in both children and adults. Moreover,
sCD44 levels in both KBD children and adult sera were sig-
niﬁcantly higher than that of normal samples. These results
are similar to that seen in analyses of other osteoarthritic
conditions18,19. The increasing levels of sCD44 in serum
may result from two different phases of the disease process.
The ﬁrst occurs when KBD etiological factors directly disturb
chondrocyte and/or CD44 metabolism, leading to CD44
shedding from cell surface. The second is that the increased
CD44 shedding results from a damage and natural repairTable II
Serum sCD44 levels (ng/ml) in normal and KBD patients
Group N sCD44 level ðX  sÞ
Normal children in non-KBD region 18 1062.01 72.84
KBD children 18 1389.86 55.62*
Normal adult in non-KBD region 20 362.72 85.16
KBD adult 20 660.88 200.50y
*P< 0.01, comparison with normal children in non-KBD region.
yP< 0.01, comparison with normal adult in non-KBD region.
Fig. 6. Immunostaining for the aggrecanase-generated BC-13 neoepitope in cartilage obtained from KBD patients and normal people. (A) Fin-
ger joint cartilage from a 12-year-old child with no known history of joint disease. (B) Finger joint cartilage from a 7-year-old KBD patient. (C)
Cartilage obtained from normal adult. (D) Cartilage obtained from an adult KBD patient. There is a signiﬁcant BC-13 positive staining in the
chondrocyte lacuna of the KBD child but no positive staining is evident in normal child cartilage. Similarly, there was no positive staining in the
normal adult cartilage but signiﬁcant BC-13 staining in the matrix of the KBD adult cartilage section.
686 J. Cao et al.: Articular cartilage metabolism in patients with KBDmechanisms. Whether the increased sCD44 levels in KBD
patients came from the ﬁrst or the second phase or both
of them is not clear at this point in time but our results indi-
cated that CD44 metabolism is altered in KBD patients
which may profoundly affect HA and proteoglycan metabo-
lism. Interestingly, sCD44 levels in serum of normal childrenFig. 7. Immunostaining for 3-B-3() CS glycosaminoglycan mimotope in
cartilage from a 3-year-old KBD patient and (B) Finger joint cartilage from
is no positive staining in the normal child cartilage, but signiﬁcant positiv
matrix staining in the KBfrom KBD region were similar with that of KBD children from
same region, and both of these were signiﬁcantly higher
than that of normal children from a non-KBD region. This
result indicates that perturbed CD44 metabolism occurs in
normal children from the KBD region although KBD pathol-
ogy is not evident in all of those affected.cartilage obtained from KBD and normal children. (A) Finger joint
a 12-year-old child with no known history of joint disease. There
e 3-B-3() staining is seen in the chondrocyte lacuna and weaker
D child cartilage.
Table III
Serum IL-1b, TNF-a and MMP-1 levels in normal and KBD patients
Group N IL-1b level (pg/ml) ðX  sÞ TNF-a level (pg/ml) ðX  sÞ MMP-1 level (ng/ml) ðX  sÞ
Normal children in non-KBD region 27 5.74 2.79*,y 18.76 5.35*,y 0.89 0.26**
Normal children in KBD region 18 31.06 6.94* 171.43 32.40* 1.09 0.64yy
KBD children 18 68.96 16.72y 88.09 18.08y 1.18 0.68
Normal adult in non-KBD region 20 2.49 0.41z 7.06 0.83z N/A
KBD adult 20 4.82 0.49z 12.10 1.10z N/A
*P< 0.05, normal children in a KBD region compared to normal children in a non-KBD region.
yP< 0.05, KBD children in a KBD region compared to normal children in a non-KBD region.
zP< 0.05, KBD adult in a KBD region compared to normal adult in a non-KBD region.
**Only 18 normal children samples in non-KBD region were analyzed.
yyOnly 11 normal children samples in KBD region were analyzed.
687Osteoarthritis and Cartilage Vol. 16, No. 6We also investigated the occurrence of evidence for the
presence of the aggrecanase-generated catabolic neoepi-
topes on aggrecan catabolites in KBD patient cartilage using
mAb BC-135. During the matrix damageerepair process,
many proteolytic enzymes such as aggrecanases and
MMPs are involved in cartilage matrix degradation. BC-13
is a monoclonal antibody used to identify the ‘‘catabolic
neoepitope’’ .NITEGE373 generated after aggrecanase
catabolism within the IGD of aggrecan. In this study, immu-
nolocation results indicated that .NITEGE373 was present
in both KBD child and adult cartilage but absent or only
weakly expressed in normal child and adult cartilage. This
ﬁnding indicates that there was active aggrecanases-
mediated aggrecan degeneration in KBD cartilage, which is
similar to that seen with OA. This study is the ﬁrst to demon-
strate that proteolytic cleavagewithin the IGD of aggrecan by
aggrecanases is involved in the pathogenesis of KBD.
The occurrence of anabolic neoepitopes generated from
aggrecan metabolism in tissue sections from normal and
KBD patients was also investigated. Expression of the
3-B-3() non-reducing terminal disaccharide neoepitope
indicates the presence of CS glycosaminoglycan chains
on newly synthesized proteoglycan, which is a marker of
altered repair or remodeling of the cartilage extracellular
matrix in degenerative joint disease6,15,16. In our analysis,
we found intense positive 3-B-3() staining in KBD child
cartilage, which suggests that the chondrocytes are at-
tempting to replace and repair proteoglycan loss caused
by KBD pathogenesis and/or its unknown etiologies.
In addition to serum levels of sCD44 we also investigated
the serum levels of the inﬂammatory cytokines (IL-1b and
TNF-a) and the MMP-1 in KBD patients, normal patients
from a KBD region and normal ‘control’ patients from an
area not affected by KBD etiologies. Both IL-1b and TNF-a
are cytokines which induce cartilage degradation in OA and
RA23,24. As expected, IL-1b and TNF-a levels in both KBD
children and adults were higher than that of the normal
group from a non-KBD area. This result is similar to that
reported in previous studies on adult KBD patients25, where
higher serum TNF-a levels were also observed in the adult
KBD group when compared to the normal group from a non-
KBD area; however, there was no difference in serum TNF-a
levels between the adult KBD patients and the normal adults
from a KBD area. Collectively, these results indicate that
these two cytokines are likely to be involved in the pathogen-
esis of KBD. Interestingly, the IL-1b level in normal children
from the KBD region was signiﬁcantly higher than that of
normal children from the non-KBD region (almost six
times higher); however, the levels were lower than that of
the KBD children from same area (i.e., 31.06 pg/ml vs
68.96 pg/ml). These results are also similar to the sCD44results presented earlier and suggest that normal children
from KBD regions are also affected by factors present in
their KBD area environment, although for some reason overt
KBD pathology does not occur in these children. Thus, there
must be some unknown factors (e.g., a genetic predisposi-
tion) that protect these ‘normal’ children from the manifesta-
tion of KBD pathology.
In summary, for the ﬁrst time, we have demonstrated that
CD44 expression and metabolism increase in the cartilage
isolated from both KBD children and adult patients. Further-
more, serum sCD44 levels from both KBD children and
adult patients are higher than that found in normal people.
These two results indicate that disturbed CD44 metabolism
occurs in KBD pathogenesis. Also, for the ﬁrst time, we
have found that there is an increased level of proteoglycan
degradation in both children and adult KBD cartilage, and
that aggrecanases are implicated in this process. In addi-
tion, both IL-1b and TNF-a are also involved in the patho-
genesis of KBD. Interestingly, several of our results
suggest that some of the inhabitants of KBD areas are
protected from the manifestation of KBD pathology.Acknowledgments
This research was supported by NSFC (Nos. 30471499,
30170831), the Key Research Foundation of Ministry of
Education of China (No. Key 03152), the Foundation of
Shaanxi Province of China (2004KW-20), BBSRC (UK)
and Arthritis Research Campaign (UK) funding. For sample
collection and treatment the authors acknowledge help from
Ming Lin, Jianhong Zhu, Zengtie Zhang and Zhilun Wang.
Two authors (BC and CEH) receive royalties from the
sale of mAbs 3-B-3 and BC-13.References
1. Yin P, Guo X. Study on the preventive and therapeutic effects of com-
prehensive method on KashineBeck disease for ten years. Endem
Dis Bull 1992;7(3):103e7.
2. Yang J. Mechanisms in occurrence and prevalence of KashineBeck dis-
ease (KBD). Chin J Endemiol 1998;17(4):201e6.
3. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT,
Giannini EH, et al. Estimates of the prevalence of arthritis and se-
lected musculoskeletal disorders in the United States. Arthritis Rheum
1998;41(5):778e99.
4. Kravchenko LF. Clinical picture and course of KashineBeck disease.
Vopr Revm 1976;3:43e51.
5. Caterson B, Flannery CR, Hughes CE, Little CB. Mechanisms involved
in cartilage proteoglycan catabolism. Matrix Biol 2000;19(4):333e44.
6. Ratcliffe A, Shurety W, Caterson B. The quantitation of a native chon-
droitin sulfate epitope in synovial ﬂuid lavages and articular cartilage
from canine experimental osteoarthritis and disuse atrophy. Arthritis
Rheum 1993;36(4):543e51.
688 J. Cao et al.: Articular cartilage metabolism in patients with KBD7. Hardingham TE, Fosang A. Proteoglycans: many forms and many func-
tions. FASEB J 1992;6(3):861e70.
8. Hascall VC, Heinegard D. Aggregation of cartilage proteoglycans. I. The
role of hyaluronic acid. J Biol Chem 1974;249(13):4232e41.
9. Flannery CR, Little CB, Hughes CE, Caterson B. Expression of
ADAMTS homologues in articular cartilage. Biochem Biophys Res
Commun 1999;260(2):318e22.
10. Arner EC. Aggrecanase-mediated cartilage degradation. Curr Opin
Pharmacol 2002;2(3):322e9.
11. Knudson W, Knudson CB. Hyaluronan receptor CD44. In: Glycoforum.
Available from: http://www.glycoforum.gr.jp/science/hyaluronan/HA10/
HA10E.html.
12. Ostergaard K, Salter DM, Andersen CB, Petersen J, Bendtzen K. CD44
expression is up-regulated in the deep zone of osteoarthritic cartilage
from human femoral heads. Histopathology 1997;31(5):451e9.
13. Takagi T, Okamoto R, Suzuki K, Hayashi T, Sato M, Sato M, et al. Up-
regulation of CD44 in rheumatoid chondrocytes. Scand J Rheumatol
2001;30(2):110e3.
14. Sato MI, Koshino T, Takagi T. CD44 expression on chondrocytes in
knees of DBA/1 mice with type II collagen-induced arthritis. Clin Exp
Rheumatol 1999;17(2):185e90.
15. Visco DM, Johnstone B, Hill MA, Jolly GA, Caterson B. Immunohisto-
chemical analysis of 3-B-3() and 7-D-4 epitope expression in canine
osteoarthritis. Arthritis Rheum 1993;36(12):1718e25.
16. Slater RR Jr, Bayliss MT, Lachiewicz PF, Visco DM, Caterson B. Mono-
clonal antibodies that detect biochemical markers of arthritis in
humans. Arthritis Rheum 1995;38(5):655e9.
17. Wang SJ, Guo X, Zuo H, Zhang YG, Xu P, Ping ZG, et al. Chondrocyte
apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articularcartilage in patients with KashineBeck disease. J Rheumatol 2006;
33(3):615e9.
18. Fuchs S, Dankbar B, Wildenau G, Goetz W, Lohmann CH,
Tibesku CO. Expression of the CD44 variant isoform 5 in the hu-
man osteoarthritic knee joint: correlation with radiological, histomor-
phological, and biochemical parameters. J Orthop Res 2004;22(4):
774e80.
19. Fuchs S, Rolauffs B, Arndt S, Tibesku CO, Prehm P. CD44H and the
isoforms CD44v5 and CD44v6 in the synovial ﬂuid of the osteoarthritic
human knee joint. Osteoarthritis Cartilage 2003 Dec;11(12):839e44.
20. Sjoberg S, Fogelstrand L, Hulthe J, Fagerberg B, Krettek A. Circulating
soluble CD44 is higher among women than men and is not associated
with cardiovascular risk factors or subclinical atherosclerosis. Metab-
olism 2005;54(2):139e41.
21. Komura K, Sato S, Fujimoto M, Hasegawa M, Takehara K. Elevated
levels of circulating CD44 in patients with systemic sclerosis: associ-
ation with a milder subset. Rheumatology (Oxford) 2002;41(10):
1149e54.
22. Niitsu N, Iijima K. High serum soluble CD44 is correlated with a poor out-
come of aggressive non-Hodgkin’s lymphoma. Leuk Res 2002;26(3):
241e8.
23. Rowan AD. Cartilage catabolism in arthritis: factors that inﬂuence
homeostasis. Available from: http://www-ermm.cbcu.cam.ac.uk.
24. Chevalier X. Upregulation of enzymatic activity by interleukin-1 in oste-
oarthritis. Biomed Pharmacother 1997;51(2):58e62.
25. Li XY, Guo X, Wang LX, Geng D, Kang LL, Wang S, et al. Serum hya-
luronic acid, tumor necrosis factor-alpha, vascular endothelial growth
factor, NO, and Se levels in adult patients with KashineBeck disease.
Nan Fang Yi Ke Da Xue Xue Bao 2007;27(7):941e4.
